- Mission [1]
- FDA's strategic priorities in responding to the public health challenges of the 21st century are to advance regulatory science
and innovation; strengthen the safety and integrity of the global supply chain; strengthen compliance and enforcement activities
to support public health; expand efforts to meet the needs of special populations; advance medical countermeasures and emergency
preparedness; advance food safety and nutrition; promote public health by advancing the safety and effectiveness of medical
products; establish an effective tabacco regulation, prevention, and control program; and manage for organizational excellence
and accountability. The Vaccines and Related Biological Products Advisory Committee supports FDA's mission and strategic action
plan by reviewing and evaluating available data relating to the safety and effectiveness of vaccines and related biological
products, which are intended for, use in the prevention, treatment, or diagnosis of human diseases. The Committee also considers
the quality and relevance of FDA's research programs which provides scientific support for the regulation of these products.
The Committee supports FDA's mission by using science-based efficient risk management in all of its activities. The Committee
recommendations provide the most health promotion and protection at the least cost for the public. This Committee assists
the Agency in ensuring timely, high quality, cost-effective processes for review of new technologies/pre-market submissions,
effective communication and working relationships with stakeholders to enhance U.S. and global health outcomes, accurately
analyzing risks associated with medical products, facilitating the development and availability of medical countermeasures
to limit the effects of a terrorist attack on the civilian and military populations, protecting the safety and security of
biologics, especially vaccines, all key components of FDA's strategic plan objectives.
|
